[CNP_P15] Poster Session 15

[CNP-P15-3] The effect of antipsychotic dose-reduction on cognition and monoamine metabolite in chronic schizophrenia patients

^○Sho HORIKOSHI^{1, 2}, Itaru MIURA², Mizue ICHINOSE^{2, 3}, Shinnosuke YAMAMOTO^{2, 4}, Masashi ITO^{2, 5}, Taishi ASANO², Chihiro YAMAMOTO⁶, Kenya WATANABE⁶, Keiko NOZAKI², Haruka KANEKO^{2, 3}, Hirooki YABE² (1. Horikoshi mental and physical clinic, 2. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan, 3. Hoshigaoka Hospital, Fukushima, Japan, 4. Fukushima Red Cross Hospital, Fukushima, Japan, 5. Yabuki Hospital, Fukushima, Japan, 6. Department of Pharmacy, Fukushima Medical University Hospital, Fukushima, Japan)